Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simonetta Buglioni

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
BMC Cancer|August 1, 2019
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypesRossano Lattanzio, Manuela Iezzi, Gianluca Sala, et al.
Cell Death & Disease|December 15, 2017
BCL-X<sub>L</sub> overexpression promotes tumor progression-associated propertiesDaniela Trisciuoglio, Maria Grazia Tupone, Marianna Desideri, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 24, 2023
Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironmentAnna Maria Lucianò, Marta Di Martile, Ana B Pérez-Oliva, et al.
The Oncologist|September 5, 2006
Chromogenic in situ hybridization to detect HER-2/neu gene amplification in histological and ThinPrep-processed breast cancer fine-needle aspirates: a sensitive and practical method in the trastuzumab eraAmina Vocaturo, Flavia Novelli, Maria Benevolo, et al.
Frontiers in Oncology|April 12, 2021
<i>PIK3CA</i> Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerNicola Fusco, Umberto Malapelle, Matteo Fassan, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2025
Impact and Reproducibility of In-House Targeted Next-Generation Sequencing Biomarker Testing in Non-Small-Cell Lung Cancer: An Italian Multi-Institutional ExperienceIda Rapa, Francesca Bertola, Gaia Roversi, et al.
Plos One|March 28, 2013
Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypesSimonetta Buglioni, Franco Di Filippo, Irene Terrenato, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 15, 2017
Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplificationCristiana Ercolani, Caterina Marchiò, Anna Di Benedetto, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 6, 2020
Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cellsMarta Di Martile, Chiara Gabellini, Marianna Desideri, et al.
Journal of Clinical Pathology|August 17, 2021
Not enough can be enough: feasibility of the Idylla <i>EGFR</i> mutation test when reuse of stained tissue slides is the only option availableCristiana Ercolani, Anna Di Benedetto, Claudia Bonomo, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
BMC Cancer|August 1, 2019
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypesRossano Lattanzio, Manuela Iezzi, Gianluca Sala, et al.
Cell Death & Disease|December 15, 2017
BCL-X<sub>L</sub> overexpression promotes tumor progression-associated propertiesDaniela Trisciuoglio, Maria Grazia Tupone, Marianna Desideri, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 24, 2023
Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironmentAnna Maria Lucianò, Marta Di Martile, Ana B Pérez-Oliva, et al.
The Oncologist|September 5, 2006
Chromogenic in situ hybridization to detect HER-2/neu gene amplification in histological and ThinPrep-processed breast cancer fine-needle aspirates: a sensitive and practical method in the trastuzumab eraAmina Vocaturo, Flavia Novelli, Maria Benevolo, et al.
Frontiers in Oncology|April 12, 2021
<i>PIK3CA</i> Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerNicola Fusco, Umberto Malapelle, Matteo Fassan, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2025
Impact and Reproducibility of In-House Targeted Next-Generation Sequencing Biomarker Testing in Non-Small-Cell Lung Cancer: An Italian Multi-Institutional ExperienceIda Rapa, Francesca Bertola, Gaia Roversi, et al.
Plos One|March 28, 2013
Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypesSimonetta Buglioni, Franco Di Filippo, Irene Terrenato, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 15, 2017
Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplificationCristiana Ercolani, Caterina Marchiò, Anna Di Benedetto, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 6, 2020
Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cellsMarta Di Martile, Chiara Gabellini, Marianna Desideri, et al.
Journal of Clinical Pathology|August 17, 2021
Not enough can be enough: feasibility of the Idylla <i>EGFR</i> mutation test when reuse of stained tissue slides is the only option availableCristiana Ercolani, Anna Di Benedetto, Claudia Bonomo, et al.
Pageof 9